Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-09-28
1995-07-25
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 16, 530324, 530326, 530329, A61K 3800, C07K 500, C07K 700, C07K 1700
Patent
active
054362288
ABSTRACT:
Peptides corresponding to an no acid sequences in the C-terminal region of TGF-.beta. are provided. The peptides all contain at least a seven amino acid sequence substantially corresponding to the amino acid sequence of TGF-.beta.1 amino acids 368-374: VYYVGRK, as well as homologs and analogs thereof. The peptides have chemotactic activity towards fibroblasts, monocytes and neutrophils and induce fibroblast proliferation and collagen synthesis. The peptides may be used in compositions and methods for promoting wound healing.
REFERENCES:
patent: 4806523 (1989-02-01), Bentz et al.
patent: 4971952 (1990-11-01), Bentz et al.
patent: 5008240 (1991-04-01), Bentz et al.
patent: 5055447 (1991-10-01), Palbdino
patent: 5061786 (1991-10-01), Burnier et al.
patent: 5104977 (1992-04-01), Sporn et al.
Jakowlew et al. Mol. Endo vol. 2 p. 1186 (1988).
Kondaiah et al. J. Biol. Chem. vol. 265, p. 1089 (1990).
Duke et al. PNAS, USA vol. 85 p. 4715 (1988).
Margvaudt et al. J. Biol. Chem. vol. 262 p. 1212t (1987).
Border et al., 1992 Tansforming Growth Factor-.beta. in Disease: The Dark Side of Tissue Repair. J. Clin. Invest., 90:1-7.
Davidson, J. M., 1992 Wound Repair. Inflammation: Basic Principles and Clinical Correlates, 2d ed., J. I. Gallin, I. M. Goldstein and R. Snyderman, eds., Raven Press, Ltd., New York chapter 39 pp. 809-819.
Flanders et al., 1988 Antibodies to Peptide Determinants in Transforming Growth Factor .beta. and Their Applications. Biochem. 27:739-746.
Massague et al., 1992 Transforming Growth Factor-.beta.. Cancer Surveys vol. 12: Tumour Suppressor Genes, the Cell Cycle and Cancer, pp. 81-103.
Postlethwaite et al., 1992 Identification of Chemotactic Epitopes of Transforming Growth Factor (TGF)-.beta.1. Arthritis and Rhumatism vol. 35, No. 9, Supplement (Abstract A62).
Postlethwaite, A., 1993 Stimulation of Elevated levels of IL-1.beta. Protein and IL-1.beta. mRNA by Snythetic TGF-.beta.1 Peptide, 337-374. ACR 57th Annual Scientific Meeting, San Antonio, Tex. (Abstract).
Postlethwait4e et al., 1987 Stimulation of the Chemotactic Migration of Human Fibroblasts by Transforming Growth Factor .beta.. J. Exper. Med., 165:251-256.
Sasaki et al., 1992 Transforming Growth Factor-.beta. in the Regulation of the Immune Response. Clinical Immunology and Immunopathology. vol. 65, 1:1-9.
Kang Andrew
Postlethwaite Arnold E.
Seyer Jerome
Huff Sheela J.
Warden Jill
LandOfFree
Chemotactic wound healing peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemotactic wound healing peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemotactic wound healing peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-739676